Vectura Share Discussion Threads

[boadicea] 17/2/2021 13:57

Brucie - I was looking at the chart and came to the same coclusion - except that the top of the rising trend channel is nearer 135p imho.
However, I am finding the company to be a disappointment given its strong but semi-redundant cash position. This has been a year of opportunity for bio-medical stocks and one feels the company could/should have been far more proactive in finding attractive situations to back. Perhaps there has been more going on than we know about in which case their silence has done them a dis-service. Millions have been pumped into the likes of Abingdon, EKF, ODX, OXB etc., for laboratory expansions and machinery to enable production scale-up. Surely VEC could have found a profitable and welcomed partnership in some of these arrangements. Instead we seem to be stuck in limbo.
All very frustrating!
Does the company deserve its continued independence?

[diesel] 17/2/2021 12:34

I would argue the value of special divvies, but like share buybacks they can be value neutral. Eg if you own £1000 Vec shares and they use 10% their mcap in giving you £100 divvie your holding is likely to be £900.
Better to use cash for value enhancing growth opportunities in M&A, or introduce a divvy
policy going forward, displaying maturity and confidence in forward earnings.
Up to now the only initiative of any significance is an incentive plan to reward the hard working execs.

[brucie5] 17/2/2021 09:26

Added again. Looks like the bottom of the retrace to me, with 1.30 as resistance. The chart keeps repeating the same pattern within an inexorably rising trend.

I could of course be wrong.
:)

[vecturaking] 17/2/2021 09:10

Results 09/03/21 well Ahead of expectations

Strong buy in my view

Results 09/03/21 will be Ahead of Expectation you have all the facts you just need to put them together

You will have a Share price over 150pence

Great Value Company with a Special Dividend in mind
For her Shareholders

Enjoy the Ride up

[pooroldboy55] 16/2/2021 16:04

Hi a Lord
Funny how some people big a company up when share price rising then disappear when down to reappear when price recovers a littl bit.

[a1ord53] 16/2/2021 15:06

Volvo, where are you with all your confidence and bullish mood for Vectura ?
Looks like market doesnt like cash and Advair approval plus China Arie and Elipta developments !
Short sellers with mm depressing share price bringing it in bear market territory .

PS Imo CDMO business is just Bonus , Vectura has strong cash flow without CDMO business.

PS2 No petition yet from GSK - tomorrow
deadline.

PS3 p/e in FTSE 250 average 30 and Vectura forward P/E 17

[polaris] 15/2/2021 10:02

@Diesel - yes, anything that has a material impact cf. what is already declared. The news everyone is talking about is stuff already mentioned in the public domain and the only reason to release another RNS is that something materially changed from first announcement.

[jeevsje] 12/2/2021 21:31

I have also heard back from IR and can confirm a few of the bullet points from bya1ord53.

[diesel] 12/2/2021 21:15

Paul, not wanting to challenge you, but surely if the is a significant event that would have any effect on share price they have to tell the market.

[polaris] 12/2/2021 19:22

There will be no news...VEC is in close period. This is why the share price is under pressure. Seen this in 2018 and 2019 and 2020...it's the opportunity for traders to test the trading channel with 'freedom'.

[pinemartin9] 12/2/2021 19:15

Looks a good entry point to me. However, I dont think there's been anything to bring in new buyers. Needs some news, general market uplift etc but stuck here for a while now. I personally feel limited downsize at these prices and offers a good risk reward ratio.

[a1ord53] 12/2/2021 17:29

Diesel and Justice,
I posted already results of my friends conversation with Vectura. Here one more time summary :
1.If Vectura hadn’t received funds, then they should make rns.
2. They will reflect receipt of GSK monies in full year results on 9th March.
3. About Elipta and eventuell milestones payment from Hikma in Hikma report on 24 Th of February.
4.Advair FDA decision may be some information in Hikma report on 24 Th of March - FDA fast track or not !
5. CDMO developments contracts details will be in Vectura results on 9 Th of March.
6 US Supreme Court dead line for GSK on 18th of February.

PS Aceuk, understood and agree with you . Imo cash can and should be returned to shareholders .

[aceuk] 12/2/2021 17:09

Don't know why you guys are focused on the GSK payment - management have no use for it (don't know what to do with it) hence clever people have no interest.

[diesel] 12/2/2021 17:04

Driven by a disappointing trading update.

[justiceforthemany] 12/2/2021 16:45

No response to my emails either. share price is in a very bearish downtrend, driven by?

[jeevsje] 12/2/2021 11:43

GBCol, thank you. I will reach out to her.

[gbcol] 12/2/2021 08:37

Jeevsje I’ve found you don’t get much (any)response from the general IR email address. I now email [e-mail] who is more likely to respond.

[jeevsje] 11/2/2021 23:54

I sent a query about the GSK funds to IR but they did not even have the decency to reply, despite my follow-up. Not sure what the person in IR does exactly but clearly, they are not giving a good impression of the company.

[boadicea] 10/2/2021 23:05

The Chance-Aerami agreement noted by jeevsje above is an interesting follow-up to the RNS-Reach issued by Vectura on 8th June 2020. The field is presumably limited as PAH is classed as a 'rare' disease - a figure of 500-1000 is quoted for new cases per annum in USA. However, the licence is a world wide one so one can potentially multiply that up by the Chinese population and the averages number of years that sufferers survive.

The Vectura nebuliser achieved a Red Dot design award in 2014.
I assume the manufacture of the nebuliser is out-sourced by Vectura - to whom? (on the picks and shovels tack.)

I find this oddly coincidental as I spent most of my working life in Chippenham and should have been making another trip to Hangzhou except for the lockdown last year and still hoping for an opportunity before too long (or at my age, before too late!).

The pharmaceutical developments are implemented notorious slowly except when something like covid-19 strikes. Perhaps the company could hitch a speedier ride on its coat-tails with an inhaled vaccine therapy?

[richman777114] 10/2/2021 20:22

the results should see confirmation of the cash at circa £200mi see 125p as a fair valuation short term but i'd love GSK to bid and get their money back that way rather than via a Supreme Court application (which would have nearly 0% chance of succeeding)IMHO DYOR

[justiceforthemany] 10/2/2021 19:13

Tesla P/E is a ludicrous 400x

Meanwhile here an offer of £1Bn could probably succeed in a takeover? Roughly 30% premium to current share price Instead of paying the fine could GSK not make an offer? Again I hope the Vectura board and Will Downie are fully transparent and are not with holding any price sensitive information or approaches. I find it very hard to believe there has not been a single one. Very hard.

[polaris] 10/2/2021 18:31

Not sure options are available for VEC - haven't looked tbh.

TSLA is a sell now, like it has been for a while. It's a calamity waiting to bring on the next US crash as it will dump the S&P too when it goes. The chip problem may well be the one that does for it, despite the fact that they are staying stum. The BTC thing is just a sideshow.

[a1ord53] 10/2/2021 18:16

Dear Paul(Polaris), please kindly let me know who is offering options on Vectura stock/shares ? Are they existing?
Is it relatively liquid ?
Never heard about but would buy some puts and calls , if its available.
Thanks a lot .

PS any idea when to sell Tesla ?

[justiceforthemany] 10/2/2021 16:44

No positive impact on the share price whatsoever. Very strange share price performance here recently.